Bulk and Single-Cell Transcriptomics Reveal That SCO2 Drives Psoriasis via Activating CCR7+ Dendritic Cell
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031397 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Donger Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Dendritic Cells, Psoriasis, Receptors, CCR7, Mitochondrial Proteins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health Research Program of Anhui.
Abstract (Originalsprache)
Metabolic reprogramming is a hallmark of psoriasis, yet the contribution of lactate metabolism to keratinocyte-mediated immune dysregulation remains undefined. Through integrated bulk and single-cell RNA sequencing, validated by immunofluorescence and metabolic assays, we identified the mitochondrial protein SCO2 as a key pathogenic hub gene upregulated in psoriatic lesions. Functionally, SCO2 overexpression promoted keratinocyte migration and triggered a metabolic shift characterized by mitochondrial pyruvate accumulation and intracellular lactate retention. Single-cell analysis further revealed that SCO2-high keratinocytes establish pathogenic crosstalk with CCR7+ dendritic cells via MIF-(CD74 + CD44) interactions, wherein these CCR7+ dendritic cells serve as the primary source of IL-23 and co-stimulatory signals (CD80/CD86) to drive robust T cell priming. Our findings highlight SCO2 as a pivotal immunometabolic switch linking keratinocyte metabolism to adaptive immunity. Targeting SCO2 offers a novel strategy to disrupt the keratinocyte-driven recruitment of CCR7+ DCs, thereby attenuating the IL-23-mediated inflammatory cascade. Furthermore, SCO2 may serve as a potential biomarker for metabolic dysregulation in psoriatic lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei 230032, China.
- Institute of Dermatology, Anhui Medical University, Hefei 230032, China.
- Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230032, China.
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, China.
ORCID-Profile: Donger Chen, Zhuo Zhu
Förderung
- National Natural Science Foundation of China
- Health Research Program of Anhui
Zitieren
APA
Chen, D., Yang, J., Zhou, G., Xu, X., Zhang, Y., Duan, Y., Liu, B., Zhu, Z., & Zhou, F. (2026). Bulk and Single-Cell Transcriptomics Reveal That SCO2 Drives Psoriasis via Activating CCR7+ Dendritic Cell. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031397
Vancouver
Chen D, Yang J, Zhou G, Xu X, Zhang Y, Duan Y, et al. Bulk and Single-Cell Transcriptomics Reveal That SCO2 Drives Psoriasis via Activating CCR7+ Dendritic Cell. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031397
BibTeX
@article{Chen2026,
author = {Chen, Donger and Yang, Jing and Zhou, Guoliang and Xu, Xiaoqing and Zhang, Yuekang and Duan, Yanting and Liu, Bin and Zhu, Zhuo and Zhou, Fusheng},
title = {Bulk and Single-Cell Transcriptomics Reveal That SCO2 Drives Psoriasis via Activating CCR7+ Dendritic Cell},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031397}
}
EUVIMED